13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A case report of multiple abscess co-infected with Eggerthella lenta and Desulfovibrio desulfuricans identificated with MALDI-TOF mass spectrometer

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sir, In this article, we report a case of multiple abscesses in a patient with history of malignancies and a recent resective colon surgery caused by two nutritionally demanding anaerobic microorganisms. E. lenta is an anaerobic non-spore- forming gram-positive bacilli belonging to the Eggerthellaceae family, which includes several bacteria commonly found in the gut microbiota [1]. D. desulfuricans are obligate anaerobic, curved, motile, sulphate-reducing, gram-negative bacilli and commensals of the gut microbiota, belonging to the Desulfovibrionaceae family. This genus comprises more than 60 species, however, only 6 have been isolated from human infections: Desulfovibrio desulfuricans, Desulfovibrio fairfieldensis, Desulfovibrio vulgaris, Desulfovibrio piger, Desulfovibrio legallii and Desulfovibrio intestinalis [2]. They are characterized by the presence of a pigment, desulfoviridin, which fluoresces red at alkaline pH and blue-green at acidic pH under long-wave-length ultraviolet light [3]. An 80-year-old woman with an ileostomy came to the emergency department with expulsion of blood-purulent contents through an infraumbilical midline incision from a recent colectomy surgery. Her medical history included an infiltrating ductal carcinoma of the breast 9 years earlier treated by quadrantectomy, axillary emptying and a combination of radiotherapy, chemotherapy and letrozole. Furthermore, she undergone an open colectomy with resection up to the trans-verse colon, splenic angle and the descending colon preserving the sigma due to complicated bowel obstruction one year ago. The patient also suffered some years ago from a moderately differentiated intestinal adenocarcinoma and poorly cohesive gastric carcinoma, being treated by total gastrectomy, chemo-therapy and radiotherapy. At the physical examination, the patient was hypotense (85/52 mmHg), eucardic (69 bpm) and afebrile (36.3ºC). A blood test showed an hemoglobin of 11.9 g/ dL, 450000 platelets (150,000-400,000), a hematocrit of 36%, normal renal and liver function, INR (International normalized ratio) of 1.3 and elevated acute phase reactants with C-reactive protein of 178 mg/L, 17000 leukocytes (4500-11000) with 91% neutrophils and fibrinogen of 856 mg/dL. A computed tomography (CT) scan showed an overinfected amphractuous pelvic collection (Figure 1A and B), extending from the intraperitoneal space in Douglas’ cul-de-sac to the anterior extra-peritoneal space where there was cutaneous fistulization, as well as an independent collection at the level of the left perisigmoid. The patient was admitted for collection drainage by interventional ultrasound, placing an anterior drainage catheter and aspirating 20 mL of purulent material. However, the collection was not completely drained and a second drainage tube was placed through the right posterior approach, aspirating another 20 ml. Two peritoneal pig-tail tub drainages, 12 Fr in diameter and 25 cm in length, were used for evacuating purulent contents of abscesses. A sample was sent to the laboratory for microbiological analysis and two sets of blood culture bottles were obtained. Finally, 250000 U of urokinase was administered and 4 g/0.5 g each 8 hours of IV piperacillin/tazobactam was prescribed. The sample was inoculated in ThioglycollateR enrichment broth, chocolate agar, Columbia CNA agar, tryptic soy agar (TSA) with 5% of sheep blood (Becton Dickinson, New Jersey, USA), Mac-Conkey agar, Brucella agar with Hemin and Vitamin K1 and Bacteroides bile esculin (BBE) agar with amikacin. Thioglyco-lateR enrichment broth, chocolate agar, CNA agar and TSA with 5% of sheep blood were incubated at 37°C under aerobic conditions with 7.5% CO2 for 96 h, McConeky agar at 37°C under aerobic conditions for 96 h, while Brucella and BBE agars were incubated at 37°C under anaerobic conditions for 72 h. Blood cultures bottles were incubated in the BDR BACTEC FX (Becton Dickinson, New Jersey, USA), being negative after five days of incubation. Figure 1 Abdominopelvic CT after contrast, axial image (A) and sagittal reconstruction (B) where we observe pelvic collections/abscesses (white arrows) with fistulization towards the straight abdominal musculature (yellow arrow). Axial (C) and sagittal (D) MIP reconstructions after placement of pig-tail catheters for drainage of the collections (white arrows). Figure 2 A: growth of brightly, transparent and tiny colonies in Brucella agar identified as Desulfovibrio desulfurican with MALDI-TOF MS. B: growth of yellowish and transparent colonies identified as Eggerthella lenta with MALDI-TOF MS. Gram staining of the sample showed 10-25 leukocytes/ field and no microorganisms. Two different microorganisms grew on Brucella agar after 72 h (Figure 2), being identified by MALDI-TOF mass spectrometer (Bruker, Massachusetts, USA) as Eggerthella lenta and Desulfovibrio desulfuricans (Figure 2) with values of 2.16 and 2.33, respectively (MALDI-TOF BiotyperR, MBT IVD, Library 9.0). The remaining culture media did not show growth. A Gram staining was performed directly from the colonies of D. desulfuricans in order to visualize its characteristic curved morphology. The antibiotic susceptibility test was performed by gradient strips or MIC Test StripR (Liofilchem, Teramo, Italy) on Brucella agar. Following CLSI breakpoints (M100, Performance Standards for Antimicrobial Susceptibility Testing, 2022), E. lenta was susceptible to amoxicillin/clavulanic acid (MIC = 0.064 mg/L), clindamycin (MIC= 0.016 mg/L) and metronidazole (MIC= 0.125 mg/L), while showing resistance to piperacillin/tazobactam (CMI = 32/4 mg/L). D. desulfuri-cans showed low MICs to amoxicillin/clavulanic acid (MIC = 0.125 mg/L), clindamycin (MIC= 0.064 mg/L) and metronidazole (MIC= 0.125 mg/L), being resistant to piperacillin/tazobactam (MIC > 256 mg/L). According to CLSI recommendations, for both susceptibility study methods (agar dilution and broth microdilution), Brucella agar and Brucella broth must be used and supplemented with Hemin, vitamin K1 and laked sheep blood, being incubated at 36ºC ± 1ºC under anaerobic conditions for 46-48 h (broth microdilution) or 42-48 h (agar dilution). Antibiotic treatment was changed to 2 g/200 mg/8 h of IV amoxicillin/clavulanic acid. Five days later, a control CT scan was performed (Figures 1C and 1D) showing a reduction of the pelvic collection. A small amount of fluid evacuated through the drainage tubes was observed some days after, in which both E. lenta and D. desulfuricans were identified again but with poor growth. The following blood tests showed a decrease in acute phase reactants and the patient improved its condition. She was finally discharged after 13 days of antibiotics with close observation of the surgical drains in the following two weeks with no treatment. The patient expired one month later after sudden worsening of the general condition. The spectrum of possible infections (both monomicrobial and polymicrobial) that can be caused by these two growth fastidious microorganisms is yet to be determined due to scarce case reports. The review of Wang J et al. describes how E. lenta can cause local infections as abscesses or systemic infections such as bacteremia due to bacterial translocation [4]. More specifically, it has been associated with infections such as liver abscesses [4], pyomyositis [5] or bacteremia [6] in the context of multiple abscesses [7], among others. D. desulfurin-cans has rarely been described in human infections, however, it has been isolated causing bacteremia [8,9], liver abscesses [10] or septic arthritis [11]. The risk factors found that predis-pose to infections by these microorganisms are those related to immunosuppression (malignancy or diabetes), gastrointestinal disease, as well as a history of trauma or previous surgery [5,8,11]. Since the growth of these microorganisms is slow and fastidious, their identification in the past has been hindered by the limitations of biochemical methods or by the scarce availability of molecular identification methods such as 16S rRNA gene sequencing in most laboratories. D. desulfuricans may be identified by growth after sodium formate/sodium fumarate stimulation, the production of different biochemical reactions such as nitrate, urea, desulfoviridin or H2S (“Sulfur, Indole, Motility” or SIM culture) or its mobility [2]. In the other hand, E. lenta does not ferment carbohydrates (the cells do not hydro-lyze esculin, hippurate and gelatin), but it produces ammonia from arginine, and H2O2 from agar medium containing 1% arginine [12]. Furthermore, E. lenta can produce H2S in a triple sugar iron agar, but cannot produce it in SIM culture medium. However, in recent years this has changed with the introduction of the MALDI-TOF mass spectrometry into the routine of many laboratories. This accurate, inexpensive and accessible tool has shortened the time needed to identify these bacteria compared to molecular methods [5, 13]. Regarding the susceptibility of E. lenta, Bo J et al. [14] reviewed the antibiotic susceptibility data of isolates between 2010 and 2020. E. lenta strains seem to be susceptible to metronidazole, amoxicillin-clavulanate, carbapenems, vancomycin and clindamycin, with high MICs in piperacillin/tazobactam and moxifloxacin in some strains. The optimal treatment has not yet been established in D. desulfuricans; however, it should be consider the possibility that this bacteria may produce beta-lactamases [15]. It could be treated with metronidazole, clindamycin, chloramphenicol or carbapenems, with variable MICs to piperacillin/tazobactam [8]. In our case, both micro-organisms showed low in-vitro activity to piperacillin-tazobactam (empirical antibiotic treatment prescribed in this case, then changed to amoxicillin/clavulanic acid), but he patient improved its condition due to a proper drainage of the collections, which emphasized how important focus control is in soft tissue and skin infections complicated with abscesses. It should be noted that empiric piperacillin/tazobactam monotherapy has been associated with an increased mortality in patient with bacteremia caused by E. lenta [16]. Therefore, piperacillin/ tazobactam monotherapy should be avoided as empiric treatment in infections caused by both anaerobic microorganisms. In addition to a correct antibiotic coverage guided by antimicrobial susceptibility, control of the focus by drainage of associated collections is essential in most of these infections [17]. The goal of source control is to eliminate the source of infection, control ongoing contamination, and restore premorbid anatomy and function.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          A new genomic blueprint of the human gut microbiota

          The composition of the human gut microbiota is linked to health and disease, but knowledge of individual microbial species is needed to decipher their biological roles. Despite extensive culturing and sequencing efforts, the complete bacterial repertoire of the human gut microbiota remains undefined. Here we identify 1,952 uncultured candidate bacterial species by reconstructing 92,143 metagenome-assembled genomes from 11,850 human gut microbiomes. These uncultured genomes substantially expand the known species repertoire of the collective human gut microbiota, with a 281% increase in phylogenetic diversity. Although the newly identified species are less prevalent in well-studied populations compared to reference isolate genomes, they improve classification of understudied African and South American samples by more than 200%. These candidate species encode hundreds of newly identified biosynthetic gene clusters and possess a distinctive functional capacity that might explain their elusive nature. Our work expands the known diversity of uncultured gut bacteria, which provides unprecedented resolution for taxonomic and functional characterization of the intestinal microbiota.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera.

            Seventeen human clinical isolates representing four species of Desulfovibrio were characterized using 16S rRNA gene sequences and tests for catalase, indole, nitrate, bile, urease, formate-fumarate stimulation, desulfoviridin, motility, and hydrogen sulfide production, plus susceptibility to antimicrobial agents. Eighty additional strains representing 10 phenotypically similar genera (Bilophila, Selenomonas, Capnocytophaga, Campylobacter, Bacteroides, Sutterella, Anaerobiospirillum, Dialister, Veillonella, and Mobiluncus) were included for comparison. All Desulfovibrio species produced H2S and were desulfoviridin positive, and all Desulfovibrio species except D. piger were motile. The four Desulfovibrio species could be distinguished from each other using tests for catalase, indole, nitrate, urease, and growth on bile, with the following results (positive [+], negative [-], growth [G], and no growth [NG]): for D. piger, -, -, -, -, and G, respectively; for D. fairfieldensis, +, -, +, -, and G, respectively; for D. desulfuricans, -, -, +, +, and NG, respectively; and for D. vulgaris, -, +, -, -, and G, respectively. Resistance to the 10-microg colistin disk separated the Desulfovibrio species from most of the other genera, which were usually susceptible. These simple tests were useful for characterizing the Desulfovibrio species and differentiating them from other phenotypically similar genera.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Desulfovibrio desulfuricans isolates from the gut of a single individual: structural and biological lipid A characterization.

              The levels of sulfate-reducing bacteria (SRB), including Desulfovibrionaceae, in the gut increase following a fat-enriched diet. Endotoxins from gut microbiota contribute to the inflammation process, leading to metabolic diseases. Thus, we sought to characterize the lipid A structures of Desulfovibrionaceae lipopolysaccharides (LPS) that are associated with the microbiota inflammatory properties. LPS variants were obtained from two SRB isolates from the gut of a single individual. These LPS variants shared similar lipid A moieties with Enterobacterial LPS, but differed from one another with regard to fatty-acid numbers and endotoxic activity. This first complete structural characterization of Desulfovibrio lipid A gives new insights into previously published data on Desulfovibrio lipid A biosynthesis. LPS microdiversity within SRBs illustrates how adaptation can influence pro-inflammatory potential.
                Bookmark

                Author and article information

                Journal
                Rev Esp Quimioter
                Rev Esp Quimioter
                Sociedad Española de Quimioterapia
                Revista Española de Quimioterapia
                Sociedad Española de Quimioterapia
                0214-3429
                1988-9518
                5 December 2023
                2024
                : 37
                : 1
                : 106-109
                Affiliations
                [1 ]Clinical microbiology service. Basurto University Hospital. Bilbao (Biscay). Spain.
                [2 ]Biocruces Bizkaia Health Research Institute. Biscay. Spain.
                [3 ]Radiodiagnosis service of Cruces University Hospital. Bilbao (Biscay). Spain
                Author notes
                Correspondence: Domingo Fernández Vecilla Basurto University Hospital. Montevideo Avenue, 18, Gurtubay pavilion, 3rd floor. 48013, Bilbao (Basque country). Spain. E-mail: domingofvec@ 123456gmail.com
                Author information
                https://orcid.org/0000-0002-4117-0888
                https://orcid.org/0000-0002-5819-0148
                https://orcid.org/0000-0002-4388-0189
                https://orcid.org/0000-0001-5818-084X
                https://orcid.org/0000-0002-0095-7430
                Article
                revespquimioter-37-106
                10.37201/req/081.2023
                10874660
                27caa561-a3f0-4086-abbe-79cbe16f0d6c
                © The Author 2023

                This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)( https://creativecommons.org/licenses/by-nc/4.0/).

                History
                : 26 June 2023
                : 15 September 2023
                : 05 October 2023
                : 30 October 2023
                Categories
                Letter to the Editor

                Comments

                Comment on this article